ATP10D expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 7.44200034930032E-10 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
3.67740000000172E-05 |
Normal-vs-Stage2 |
4.314400E-02 |
Normal-vs-Stage3 |
9.43689570931383E-15 |
Normal-vs-Stage4 |
3.32609495501401E-11 |
Stage1-vs-Stage2 |
8.006800E-01 |
Stage1-vs-Stage3 |
6.40200000012747E-07 |
Stage1-vs-Stage4 |
1.019420E-04 |
Stage2-vs-Stage3 |
2.256300E-02 |
Stage2-vs-Stage4 |
2.573800E-02 |
Stage3-vs-Stage4 |
9.119200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.81549997257946E-09 |
Normal-vs-AfricanAmerican |
7.40479999983279E-07 |
Normal-vs-Asian |
3.817700E-02 |
Caucasian-vs-AfricanAmerican |
4.012200E-01 |
Caucasian-vs-Asian |
9.037800E-01 |
AfricanAmerican-vs-Asian |
6.568400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.6860000062735E-09 |
Normal-vs-Female |
1.96839999855314E-08 |
Male-vs-Female |
6.480800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
3.84850000000325E-05 |
Normal-vs-Age(41-60Yrs) |
1.61570000001277E-06 |
Normal-vs-Age(61-80Yrs) |
2.87449952729446E-10 |
Normal-vs-Age(81-100Yrs) |
3.47310000003986E-06 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.290400E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.645600E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.718600E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.841900E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.588100E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.995800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
1.287610E-01 |
Normal-vs-Grade 2 |
4.1939999999574E-06 |
Normal-vs-Grade 3 |
8.29459834150725E-11 |
Normal-vs-Grade 4 |
2.596034498481E-12 |
Grade 1-vs-Grade 2 |
2.726400E-01 |
Grade 1-vs-Grade 3 |
6.478400E-02 |
Grade 1-vs-Grade 4 |
4.118500E-03 |
Grade 2-vs-Grade 3 |
7.056900E-03 |
Grade 2-vs-Grade 4 |
1.018490E-04 |
Grade 3-vs-Grade 4 |
2.158400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.33859999973396E-07 |
Normal-vs-ccB subtype |
5.70819999999861E-05 |
ccA subtype-vs-ccB subtype |
8.893800E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.37520000054181E-07 |
Normal-vs-N1 |
3.94660000000435E-05 |
N0-vs-N1 |
1.818350E-01 |
|
|